Q-FASTR Records

View as cards View as table106 Projects

	Fiscal Year Awarded	Principal Investigator
Induction of autoantigen-specific tolerance to reverse type 1 diabetes	2027	Amy Wagers
Quantitative field-deployable diagnostic	2027	Michael Springer
Tuning p53-Dependent Cell Fate for Radioprotection/Mitigation	2027	Galit Lahav
Validating novel therapeutic targets in pulmonary arterial hypertension	2027	Adrian Salic
A degrader approach to mechanism-based therapeutics in pulmonary arterial hypertension	2026	Adrian Salic
A new approach to decode gene-based mechanisms and advance therapeutic options for cardiovascular disease and other aging-related disorders	2026	Amy Wagers
Advancing the development of HUWE1 inhibitors for cancer treatment	2026	Ying Lu
Bacterial siderophores for accelerated mineral weathering and carbon sequestration in seawater	2026	Pamela Silver
Brain specific modulation of thyroid hormone levels	2026	Bernardo Sabatini
Development of a novel therapeutic to accelerate epithelial repair following viral respiratory infection	2026	Ruth Franklin
Development of targeted ectodomain shedding molecules	2026	Stephen Blacklow
Enhanced dual-AAV gene delivery to treat hereditary deafness	2026	David Corey
Enhancing regulatory T cell function for adoptive CAR Treg therapy to treat autoimmune disease	2026	Arlene Sharpe
Melanocortin 1 receptor agonists for preventing skin cancer	2026	Andrew Kruse
Non-invasive theranostics for endometriosis	2026	Ulrich von Andrian
Potassium channel enhancers to treat pain and epilepsy	2026	Bruce Bean
Potassium channel inhibitors for symptomatic treatment of multiple sclerosis	2026	Bruce Bean
Precision modulation of IL-10 pathways via IL-10 receptor-targeted nanobodies	2026	Jun Huh
Purification pipeline	2026	Michael Springer
Relaxin family peptide receptor 2 modulators as therapeutics	2026	Andrew Kruse

Q-FASTR Records

Filter Q-FASTR Records

Fiscal Year Awarded

Funding amount

Principal Investigator